Women’s health matters: Gender-specific medicine

For centuries, women’s health research and healthcare practices have been predominantly male-dominated, often overlooking the physiological and biological differences between men and women. However, as scientific advancements reveal the unique ways in which diseases manifest and progress in women, gender-specific medicine has emerged as a crucial field. Recognising these differences is essential for improving diagnosis, treatment, and overall health outcomes for women worldwide.

Why women’s health matters in medicine

1. Biological differences affect disease manifestation

It is well established that men and women can suffer from the same diseases but often exhibit different symptoms. For example, cardiovascular diseases in women frequently present with atypical signs, leading to delays in diagnosis and treatment. Similarly, conditions like osteoporosis, autoimmune diseases, and certain cancers predominantly affect women, necessitating specialised approaches to prevention and care.

2. Differences in drug responses and side effects

Historically, clinical trials have largely excluded women, resulting in a lack of understanding of how medications affect female physiology. Women metabolise drugs differently due to hormonal fluctuations and differences in body composition. This impacts both drug efficacy and the risk of adverse reactions, making women’s health research crucial for safer treatments.

3. Women’s mental health and neurological disorders

Women are twice as likely as men to experience depression and anxiety. Mental health research has often ignored hormonal and social factors affecting female well-being. Similarly, diseases like Alzheimer’s disproportionately impact women, highlighting the need for targeted research and treatment strategies.

4. Reproductive and maternal health in women’s medicine

Conditions such as endometriosis, polycystic ovary syndrome (PCOS), and pregnancy-related complications require specialised attention. Women’s health-focused medicine ensures reproductive issues receive the research funding and medical focus they deserve, improving early diagnosis and treatment options.

Data on women’s health disparities

• Women are 50% more likely than men to receive an incorrect diagnosis after a heart attack.
• Over 75% of autoimmune disease cases occur in women, yet research remains underfunded.
• From 1997 to 2000, 8 out of 10 drugs withdrawn from the market posed higher risks for women.
• Women experience adverse reactions to medications nearly twice as often as men.
• Female patients with chronic pain are more likely to be prescribed antidepressants rather than pain medication.

Advances in research and treatment

Recent advancements in medical research have led to tangible improvements in healthcare for women. Some key developments include:

• Breast cancer and genetic research: Studies on BRCA1 and BRCA2 gene mutations have significantly improved early detection and treatment strategies. Research led by institutions like the Stanford Women’s Health and Sex Differences in Medicine Center has transformed how high-risk individuals are monitored and treated.
• Safer drug development for women: Regulatory agencies now require sex-based analysis in clinical trials. The National Institutes of Health (NIH) has enforced policies ensuring female representation in studies, reducing the likelihood of adverse drug reactions in women.
• Cardiovascular disease awareness: The American Heart Association (AHA) has launched campaigns to educate healthcare professionals on how heart disease presents differently in women. This has led to improved diagnostic protocols and treatment approaches.
• Impact of the COVID-19 pandemic on sex-based research: Scientists discovered that men were more likely to suffer severe outcomes from COVID-19, while women experienced higher rates of long Covid. This has reinforced the necessity of considering biological differences in immune response research.

While challenges remain, these advancements show that increased focus on gender-specific research leads to better medical outcomes for women.. Some notable advancements include:

• Better understanding of genetic factors: Research on high-risk genes for diseases like breast cancer has transformed prevention, early detection, and treatment strategies.
• Improved drug testing for women: The pharmaceutical industry now considers biological differences in drug trials, reducing risks of adverse reactions.
• Insights from the COVID-19 pandemic: Studies found men were more likely to die from COVID-19, while women had higher chances of developing Long Covid. These findings reinforce the importance of sex-based research in medicine.

The future of women’s health in medicine

It is crucial for healthcare professionals to understand how certain conditions manifest differently in women. However, the lack of investment in gender-specific medicine has made it difficult to access high-quality, evidence-based resources. At Xpeer, we are committed to closing this gap. Our courses are accredited by the UEMS, ensuring they meet rigorous quality and scientific standards. Join today and enhance patient outcomes for women.

Women’s health research is not just about equity; it is about improving healthcare for half of the world’s population. Addressing biological and physiological needs enhances diagnostics, treatment, and overall well-being. As research evolves, a gender-sensitive approach in medicine will lead to better outcomes for women, ensuring they receive the care they deserve